rf-fullcolor.png

 

March 30, 2012
by Alexander Gaffney, RAC

EMA Application, MAH Fees Set to Rise 3.1% on 1 April

The European Medicines Agency (EMA) is preparing to raise fees by 3.1% on 1 April 2012 for all applicants and marketing-authorization holders (MAHs), the agency said in a statement.

"Every year, the Agency adjusts its fees on 1 April, in line with the European Union (EU) inflation rate for the previous year," said EMA in a statement posted on its website. "All applications received at the Agency by 31 March 2012 will be charged at the current fee and reduction rates. Applications received after that date will be charged the adjusted fees."

EMA released a compendium of documents to guide and advise industry on the full details of the fees and its structure, which is available in the "read more" section below.


Read more:

EMA - Increased fees coming into effect on 1 April 2012

Guidance - Fees payable to the European Medicines Agency
×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.